Overview

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Takeda
Treatments:
Candesartan
Candesartan cilexetil